Cite
HARVARD Citation
Behr, J. et al. (2021). Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet. 9 (5), pp. 476-486. [Online].